Skip to main content
Supplement ScienceSupplementScience

Benefits of Akkermansia

Evidence:Emerging
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Gut barrier integrity — Akkermansia feeds on and stimulates production of mucin, the protective gel layer lining the intestinal wall, strengthening the gut barrier against endotoxins
  • Metabolic health — a landmark 2019 RCT by Depommier et al. found pasteurized Akkermansia improved insulin sensitivity, reduced insulinemia, and decreased total plasma cholesterol in overweight/obese subjects
  • GLP-1 pathway support — Akkermansia produces short-chain fatty acids and interacts with Toll-like receptor 2 (TLR2), which may indirectly support GLP-1 secretion from intestinal L-cells
  • Body composition — preclinical and early clinical data suggest Akkermansia supplementation reduces fat mass gain and improves markers of metabolic syndrome
  • Reduced systemic inflammation — by improving gut barrier function, Akkermansia reduces the translocation of lipopolysaccharide (LPS) into the bloodstream, lowering chronic low-grade inflammation

What the Research Says

Akkermansia muciniphila is a probiotic strain linked to metabolic health benefits. A 2019 randomized controlled trial by Depommier et al. demonstrated that pasteurized Akkermansia supplementation improved insulin sensitivity, reduced insulinemia by 28%, and decreased total cholesterol in overweight/obese volunteers over 3 months. Pasteurization enhances the bioavailability of Amuc_1100, a heat-stable protein associated with metabolic benefits (Depommier et al., 2019).

Recent studies further validate Akkermansia's efficacy. Zhang et al. (2025) conducted a 12-week RCT involving 58 overweight/obese individuals with type 2 diabetes and found that supplementation improved metabolic outcomes, particularly in those with low baseline levels of the bacterium. Additionally, Kang et al. (2024) reported that pasteurized Akkermansia HB05P enhanced muscle strength and function in a 12-week RCT.

As of 2025, Akkermansia has received Novel Food approval from the European Food Safety Authority (EFSA), confirming its safety profile for human consumption. These findings highlight Akkermansia's potential as a therapeutic intervention for metabolic disorders; however, further research is needed to fully elucidate its mechanisms and optimize its application.

Related Conditions

Gut HealthBlood Sugar
Ready to try Akkermansia?
See our independently tested and ranked picks
Full Akkermansia Guide

References

  1. RCTDepommier C, Everard A, Druart C, et al. (2019). Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine. DOI PubMed
  2. ReviewCani PD, de Vos WM (2017). Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila. Frontiers in Microbiology. DOI PubMed
  3. RCTZhang Y, Liu R, Chen Y, Cao Z, et al. (2025). Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut.. Cell metabolism. DOI PubMed
  4. Mörkl S, Narrath M, Schlotmann D, Sallmutter MT, et al. (2025). Multi-species probiotic supplement enhances vagal nerve function - results of a randomized controlled trial in patients with depression and healthy controls.. Gut microbes. DOI PubMed
  5. Climent E, Hevilla F, Padial M, Barril-Cuadrado G, et al. (2025). Psychobiotic Protection of Nutritional Supplements and Probiotics in Patients Undergoing Hemodialysis: A Randomized Trial.. Nutrients. DOI PubMed
  6. Tsai YS, Lin XB, Lin SW, Chen YL, et al. (2025). Impact of probiotic Lactobacillus plantarum GKM3 on gastrointestinal health in overweight and obese individuals: A randomized clinical trial.. Clinical nutrition ESPEN. DOI PubMed
  7. Tana C, Moffa S, Tana M, Ucciferri C, et al. (2025). Gut Microbiota, Mild Cognitive Impairment and Dementia: A Systematic Review.. Neurology international. DOI PubMed
Show 3 more references
  1. RCTKang CH, Jung ES, Jung SJ, Han YH, et al. (2024). Pasteurized Akkermansia muciniphila HB05 (HB05P) Improves Muscle Strength and Function: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.. Nutrients. DOI PubMed
  2. Jardon KM, Goossens GH, Most J, Galazzo G, et al. (2024). Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity.. Gut microbes. DOI PubMed
  3. Calvani R, Giampaoli O, Marini F, Del Chierico F, et al. (2024). Beetroot juice intake positively influenced gut microbiota and inflammation but failed to improve functional outcomes in adults with long COVID: A pilot randomized controlled trial.. Clinical nutrition (Edinburgh, Scotland). DOI PubMed